Results 191 to 200 of about 132,893 (224)
Some of the next articles are maybe not open access.
Thromboxane B2 in dogs with babesiosis
2006Babesiosis can cause severe tissue hypoxia with consequent widespread tissue damage and probable release of inflammatory mediators (Lobetti, 1998). The major mediators are cytokines, nitric oxide, free oxygen radicals, eicosanoids, and platelet-activating factor (Purvis et al., 1994).
Kučer, Nada +6 more
openaire +1 more source
The Role of Thromboxane in the Course and Treatment of Ischemic Stroke: Review
International Journal of Molecular Sciences, 2021Malgorzata Szczuko +2 more
exaly
Fractional conversion of thromboxane B2 to urinary 11-dehydro-thromboxane B2 in man
Pharmacological Research Communications, 1988G. Ciabattoni +4 more
openaire +1 more source
METABOLISM OF THROMBOXANE B2 IN MAN
Prostaglandins, 1978L.J. Roberts, B.J. Sweetman, J.A. Oates
openaire +2 more sources
CLINICAL SIGNIFICANCE OF THROMBOXANE B2
Acupuncture & Electro-Therapeutics Research, 2006Karo Maeda, Tadashi Motomura
openaire +1 more source
Radioimmunological determination of thromboxane release in cardiac anaphylaxis
European Journal of Pharmacology, 1977H Anhut, W Bernauer, B A Peskar
exaly